Turval B0399® Characterization
Human Health
Food Science
Animal Health

Oral Health

Halitosis treatment with Kluyveromyces B0399

Trial 168: Halitosis treatment through the administration of antibiotic-resistant lactic yeast Kluyveromyces marxianus fragilis B0399 (K-B0399) Cecchini F.1, Nobili A.2, Zanvit A. 3, Miclavez A.4, No

PENDING PATENT: Topical, oral pharmaceutical composition for use in the treatment of inflammatory diseases of the oral cavity

The present patent relates to the use of Kluyveromyces marxianus fragilis B0399 in the treatment of inflammatory diseases of the oral cavity BACKGROUND: The project Parobio and the described patent

Developed by Creative Web

2025. © All rights reserved. Laboratori Turval Italia srl (TURVAL Laboratories Ltd.) - Head Office and Research Dpt: Friuli innovazione (AREA international Science Park-TS), Via Linussio 51-33100 Udine (IT) – P. IVA 01883020305

Oral Health

TURVAL

WE VALUE YOUR PRIVACY